The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab and paclitaxel in refractory extensive disease small cell lung cancer.
 
YuJung Kim
No Relationships to Disclose
 
Bhumsuk Keam
No Relationships to Disclose
 
Chan-Young Ock
Employment - Theragen Etex
 
Sanghoon Song
Employment - Theragen Etex
 
Miso Kim
No Relationships to Disclose
 
Se Hyun Kim
No Relationships to Disclose
 
Ki Hwan Kim
No Relationships to Disclose
 
Jin-Soo Kim
Stock and Other Ownership Interests - Chong Kun Dang Pharmaceutical; DAEHWA Pharmaceutical
Honoraria - CJ Healthcare; Merck
Consulting or Advisory Role - CJ Healthcare; DAEHWA Pharmaceutical; Lilly
Research Funding - AstraZeneca; Boehringer Ingelheim; Chong Kun Dang Pharmaceutical; CJ Healthcare; Hanmi; Lilly; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Tae Min Kim
No Relationships to Disclose
 
Dong-Wan Kim
No Relationships to Disclose
 
Jong Seok Lee
No Relationships to Disclose
 
Dae Seog Heo
No Relationships to Disclose